
News • Weight loss and diabetes medication
GLP-1 agonists may interfere with cancer imaging, new study finds
GLP-1 receptor agonists are widely prescribed for individuals with diabetes and weight loss. However, these medications may adversely affect the interpretation of cancer imaging, new research finds.